001     137604
005     20240229105112.0
024 7 _ |a 10.1080/15592294.2018.1460034
|2 doi
024 7 _ |a pmid:29697014
|2 pmid
024 7 _ |a pmc:PMC6140810
|2 pmc
024 7 _ |a 1559-2294
|2 ISSN
024 7 _ |a 1559-2308
|2 ISSN
024 7 _ |a altmetric:39371719
|2 altmetric
037 _ _ |a DKFZ-2018-01484
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Klett, Hagen
|0 P:(DE-He78)7d9e1d38f0a7c93258298b0cbb17889c
|b 0
245 _ _ |a Robust prediction of gene regulation in colorectal cancer tissues from DNA methylation profiles.
260 _ _ |a Austin, Tex.
|c 2018
|b Landes Bioscience
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1659959103_8495
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a DNA methylation is recognized as one of several epigenetic regulators of gene expression and as potential driver of carcinogenesis through gene-silencing of tumor suppressors and activation of oncogenes. However, abnormal methylation, even of promoter regions, does not necessarily alter gene expression levels, especially if the gene is already silenced, leaving the exact mechanisms of methylation unanswered. Using a large cohort of matching DNA methylation and gene expression samples of colorectal cancer (CRC; n = 77) and normal adjacent mucosa tissues (n = 108), we investigated the regulatory role of methylation on gene expression. We show that on a subset of genes enriched in common cancer pathways, methylation is significantly associated with gene regulation through gene-specific mechanisms. We built two classification models to infer gene regulation in CRC from methylation differences of tumor and normal tissues, taking into account both gene-silencing and gene-activation effects through hyper- and hypo-methylation of CpGs. The classification models result in high prediction performances in both training and independent CRC testing cohorts (0.92
536 _ _ |a 313 - Cancer risk factors and prevention (POF3-313)
|0 G:(DE-HGF)POF3-313
|c POF3-313
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a Balavarca, Yesilda
|0 0000-0002-4950-0554
|b 1
700 1 _ |a Toth, Reka
|0 P:(DE-He78)cd2ec3f2ae9b2178f113e0f2ed15fc48
|b 2
700 1 _ |a Gigic, Biljana
|0 P:(DE-He78)bf23868ef13533194e6881f2c5445e81
|b 3
700 1 _ |a Habermann, Nina
|0 P:(DE-HGF)0
|b 4
700 1 _ |a Scherer, Dominique
|0 P:(DE-He78)0e36ebe046be3cabb1c2e282725180b9
|b 5
700 1 _ |a Schrotz-King, Petra
|0 P:(DE-He78)01ef71f71b01a3ec3b698653fd43fe86
|b 6
700 1 _ |a Ulrich, Alexis
|b 7
700 1 _ |a Schirmacher, Peter
|b 8
700 1 _ |a Herpel, Esther
|b 9
700 1 _ |a Brenner, Hermann
|0 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2
|b 10
700 1 _ |a Ulrich, Cornelia M
|0 P:(DE-HGF)0
|b 11
700 1 _ |a Michels, Karin B
|b 12
700 1 _ |a Busch, Hauke
|b 13
700 1 _ |a Boerries, Melanie
|0 0000-0002-3670-0602
|b 14
773 _ _ |a 10.1080/15592294.2018.1460034
|g Vol. 13, no. 4, p. 386 - 397
|0 PERI:(DE-600)2248598-3
|n 4
|p 386 - 397
|t Epigenetics
|v 13
|y 2018
|x 1559-2308
909 C O |p VDB
|o oai:inrepo02.dkfz.de:137604
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-He78)7d9e1d38f0a7c93258298b0cbb17889c
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 0000-0002-4950-0554
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 2
|6 P:(DE-He78)cd2ec3f2ae9b2178f113e0f2ed15fc48
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 3
|6 P:(DE-He78)bf23868ef13533194e6881f2c5445e81
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 4
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 5
|6 P:(DE-He78)0e36ebe046be3cabb1c2e282725180b9
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 6
|6 P:(DE-He78)01ef71f71b01a3ec3b698653fd43fe86
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 10
|6 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 14
|6 0000-0002-3670-0602
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-313
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Cancer risk factors and prevention
|x 0
914 1 _ |y 2018
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b EPIGENETICS-US : 2015
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
920 1 _ |0 I:(DE-He78)L601-20160331
|k L601
|l DKTK Freiburg
|x 0
920 1 _ |0 I:(DE-He78)G110-20160331
|k G110
|l Präventive Onkologie
|x 1
920 1 _ |0 I:(DE-He78)C070-20160331
|k C070
|l C070 Klinische Epidemiologie und Alternf.
|x 2
920 1 _ |0 I:(DE-He78)L101-20160331
|k L101
|l DKTK Heidelberg
|x 3
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)L601-20160331
980 _ _ |a I:(DE-He78)G110-20160331
980 _ _ |a I:(DE-He78)C070-20160331
980 _ _ |a I:(DE-He78)L101-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21